Show all Hide all

Download this Press release (PDF Format)Download Print Back
Ordinary and Extraordinary General Meeting, 26 June 2013   (22/05/2013 18:00)

Avignon, May 22th, 2013 - NATUREX, the world leader in specialty plant-based natural ingredients, informs its shareholders that the Ordinary and Extraordinary General Meeting will be held on:

 

Wednesday 26th June 2013 at 10:00am
NYSE EURONEXT - Auditorium Cambon
39 rue Cambon
75001 Paris

 

NATUREX welcomes its shareholders to consult on the Company's website (www.naturex.com), the preliminary meeting notice that has been published today in the Official Bulletin (BALO - Bulletin des Annonces Légales Obligatoires) and that notably includes the agenda, the draft resolutions and details on attending and voting at the General Meeting.

All the documents and information relating to this General Meeting will be communicated, posted on line and made available at the Company's registered office, in compliance with French legal and regulatory requirements.

 

  • Next publication
  • 1st quarter results 2013 : 29th May 2013

 

If you would like to receive financial information about Naturex by e-mail, go to: www.naturex.com

 

Naturex has been listed on NYSE Euronext Paris, Compartment B (Mid Caps), since October 1996.

NATUREX Total number of shares comprising the share capital: 7,821,355
ISIN FR0000054694

Naturex is a component of the CAC Small and Gaïa indexes.
Naturex is eligible for "long only" Deferred Settlement Service (SRD).
Naturex established a Sponsored Level 1 American Depositary Receipt (ADR) program in the United States. Under this facility, Naturex's ADRs are traded over-the-counter in the United States under the symbol NTUXY.

SYMBOL: NRX - Reuters: NATU.PA - Bloomberg: NRX:FP - DR Symbol: NTUXY

 

About Naturex
Naturex is the global leader in speciality plant-based natural ingredients.
The Group is organised around three strategic markets (food & beverage, nutrition & health and personal care) and produces and markets speciality plant-based ingredients for the food, nutraceutical, pharmaceutical and cosmetic industries.

Naturex's head office is based in Avignon. The company employs more than 1,400 people with high-performance manufacturing operations across 15 sites in Europe (France, Italy, Spain, the United Kingdom, Switzerland, Poland) as well as in Morocco, the United States, Brazil, Australia and India. It also has a global presence through a dedicated network of sales offices in 20 countries (France, Italy, Spain, Morocco, the United Kingdom, Belgium, Germany, Poland, Russia, U.A.E., Thailand, Japan, China, Korea, Australia, the United States, Canada, Brazil, Mexico and India).

Naturex's development is supported by positive underlying trends linked to the fast-growing demand for natural products and its capacity to provide manufacturers customised solutions to meet the requirements of their end consumers. The Group's strength lies in its positioning with specific products which constitute niche markets, supported by strong sourcing capacity and sustained research & development.

 

Contacts  
Thierry Lambert
Chairman and Chief Executive Officer
Tel: +33 (0)4 90 23 96 89
t.lambert@naturex.com
Thierry Bertrand Lambert
Chief Financial Officer
Tel: +33 (0)4 90 23 96 89
t.blambert@naturex.com
Carole Alexandre
Investor Relations
Tel: +33 (0)4 90 23 78 28
c.alexandre@naturex.com
Anne Catherine Bonjour
Actus Finance Press Relations
Tel: +33 (0)1 53 67 36 93
acbonjour@actus.fr
Download this Press release (PDF Format)Download Print Back